Epilepsy is a chronic disease that causes repeated seizures caused by abnormal electrical activity caused by damaged brain cells. It affects millions of people worldwide and can disrupt their ...

After experiencing seizures every other week, Christine Kauzen has been seizure-free for months since receiving a rare ...

When you hear the word epilepsy, what comes to mind? For many, it rsquo;s a vague image of someone having a seizure ndash; ...

Sean Lew, recommended the responsive neurostimulation procedure or RNS. "For epilepsy surgery, traditionally, the treatment is to find the part of the brain causing seizures and removing that part ...

NeuroPace is known for its innovative RNS System, the first brain-responsive platform that provides personalized treatment to manage seizures in patients with drug-resistant epilepsy, potentially ...

NeuroPace unveiled the data as part of a series of poster presentations at the American Epilepsy Society’s annual meeting in Washington, D.C. Silicon Valley-based NeuroPace claims its RNS System ...

(NASDAQ:NPCE), a medical device company specializing in neurological disorders, has been making significant strides in the epilepsy treatment market with its Responsive Neurostimulation (RNS ...

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as ...

RN reviews safety, expectations ... Buchhalter, PhD MD, is the former director of the pediatric epilepsy program in the Mayo Clinic Department of Neurology, Rochester, MN.

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Full-year 2025 revenue guidance of $92 to $96 million -- -- Completed an underwritten public offering of $74.8 million, using $49.5 million of the net proceeds to repurchase 100% of KCK holdings and ...